Enucleation Refusal for Retinoblastoma: A Global Study

Area of Science:

• Pediatric Oncology
• Ophthalmology

Background:

• Enucleation (eye removal) is the primary curative treatment for retinoblastoma, a common childhood eye cancer.
• Parental refusal of enucleation frequently leads to delayed treatment and reduced survival rates globally.

Purpose of the Study:

• To investigate the reasons behind parental refusal of enucleation for retinoblastoma treatment.
• To identify factors influencing treatment compliance in pediatric cancer care.

Main Methods:

• A survey was conducted among physicians treating retinoblastoma patients.
• Data collected focused on enucleation refusal rates and associated factors.

Main Results:

• Higher enucleation refusal rates correlated with less physician-parent communication time regarding retinoblastoma and enucleation.
• Limited availability of support services was associated with increased refusal.
• Key reasons for refusal included belief in alternative therapies, cultural factors, and social stigma.

Conclusions:

• Implementing strategies to enhance parental understanding and support is crucial for improving enucleation compliance.
• Addressing cultural beliefs and social stigma can help overcome barriers to life-saving retinoblastoma treatment.
• Effective communication and robust support systems are vital for saving children's lives affected by retinoblastoma.